Related Articles

• Pathotropic targeting advances clinical oncology: Tumor-targeted localization of therapeutic gene delivery
• Le morte du tumour: Histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes
• Pathotropic nanoparticles for cancer gene therapy Rexin-G™ IV: Three-year clinical experience
• First clinical experience using a ‘pathotropic’ injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer
• Targeting metastatic cancer from the inside: A new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ